Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics
FDA-SSN-CBER-2023-116031
See revised sources sought notice and revised draft SOW.